Personalized promotion on regular sports and soybean intake and precision treatment based on DNA methylation markers (OPRM1) should be encouraged with the consideration of the correlation between OPRM1 hypermethylation and ER/PR, HER-2 negative status in breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.